ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685833 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685833; 2) Community: the network communities that were significantly associated with the response to NSC 685833; 3) Molecule: the relationships between components within communities and NSC 685833; 4) MDR: the compounds that were significantly associated with the NSC 685833.

NSC Compound Enrichment Correlation
NSC 716503 Null 0.0135714101922724 0.18635546
NSC 717468 Null 0.0135714101922724 0.28888789
NSC 725098 Null 0.0135714101922724 0.25042365
NSC 726217 Combretastatin A4-analogue 0.0135714101922724 0.23971587
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0135714101922724 0.4787212
NSC 750050 Null 0.0135714101922724 0.42978505
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0135714101922724 -0.057867325
NSC 753598 Null 0.0135714101922724 0.34714943
NSC 85561 3-hydroxy-4-((1-hydroxynaphthalen-2-yl)diazenyl)-7-nitronaphthalene-1-sulfonic acid, sodium sallt 0.0135714101922724 0.3864656
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0139796580235792 0.34499313
Total:144  Current:63    [First] [Prev] [Next] [Last]